Cargando…
EFFECTS OF SPLEEN STATUS ON EARLY OUTCOMES AFTER HEMATOPOIETIC CELL TRANSPLANTATION
To assess the impact of spleen status on engraftment and early morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT), we analyzed 9,683 myeloablative allograft recipients from 1990 to 2006; 472 had prior splenectomy (SP), 300 splenic irradiation (SI), 1,471 with splenomeg...
Autores principales: | Akpek, Görgün, Pasquini, Marcelo C., Logan, Brent, Agovi, Manza-A, Lazarus, Hillard M., Marks, David I., Bornhaeüser, Martin, Ringdén, Olle, Maziarz, Richard T., Gupta, Vikas, Popat, Uday, Maharaj, Dipnarine, Bolwell, Brian J., Rizzo, J. Douglas, Ballen, Karen K., Cooke, Kenneth R., McCarthy, Philip L., Ho, Vincent T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606905/ https://www.ncbi.nlm.nih.gov/pubmed/23222382 http://dx.doi.org/10.1038/bmt.2012.249 |
Ejemplares similares
-
Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
por: Olsson, Richard F., et al.
Publicado: (2015) -
The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV
por: Anikpo, Ifedioranma, et al.
Publicado: (2021) -
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYCOSIS FUNGOIDES AND SEZARY SYNDROME
por: Lechowicz, Mary Jo, et al.
Publicado: (2014) -
Knowledge needs for implementing HIV pre-exposure prophylaxis among primary care providers in a safety-net health system
por: Agovi, Afiba Manza-A., et al.
Publicado: (2020) -
Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome
por: Maharaj, Dipnarine, et al.
Publicado: (2021)